Axsome Therapeutics, Inc.AXSMNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+109.0%
Studio
Year-over-Year Change

Direct costs attributable to producing goods sold

3Y CAGR
+109.0%/yr
vs +221.0%/yr prior
Acceleration
-112.0pp
Decelerating
Percentile
P100
Near historical high
vs 3Y Ago
9.1x
Strong expansion
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$47.48M+42.6%
2024$33.30M+27.8%
2023$26.07M+401.4%
2022$5.20M-
2021$0.00-
2020$0.00-100.0%
2019$37330.00-23.7%
2018$48935.00+15.0%
2017$42557.00+107.8%
2016$20484.00-